AME

AMETEK, Inc.

Next est. report 2026-10-29 · BMO

Data Centers '25: Energy Storage & Backup Humanoid '25: Actuator Hardware Space Supply Chain '26: Aerospace Fasteners, Seals & Connectors

Loading…

Loading chart…

Overview

AMETEK, Inc. develops and markets electronic instruments and electromechanical devices across two segments. Its Electronic Instruments Group (EIG) provides adva

AMETEK, Inc. develops and markets electronic instruments and electromechanical devices across two segments. Its Electronic Instruments Group (EIG) provides advanced solutions for process control, aerospace, and semiconductors, representing about 65% of sales. The Electromechanical Group (EMG) offers motion control, specialized materials, and thermal management for MedTech, defense, and automation, comprising about 35% of sales, serving diverse industrial and specialized markets.

Search Keywords Brand Product

RTDS Technologies
Zygo metrology
Paragon Medical
Hughes-Treitler heat exchangers
Alphasense oxygen sensor
Creaform 3D scanners
Solidstate Controls UPS
electronic instruments
electromechanical devices
AI infrastructure
data center power
defense modernization
MedTech components
aerospace sensors
power grid solutions
precision automation
semiconductor manufacturing equipment

Search Keywords Event Phrases

AMETEK Q2 2026 earnings
Indicor acquisition

What They Do (Plain English & Analogies): AMETEK, Inc. is like a specialized toolkit provider for a wide range of industries. They essentially make two main types of sophisticated tools: 'smart sensors and testers' through their Electronic Instruments Group (EIG) and 'precision parts and motors' via their Electromechanical Group (EMG). The smart sensors are highly accurate diagnostic tools used in critical applications, such as monitoring factory processes, ensuring the safety of airplane engines, or managing complex power grids. The precision parts are like the finely crafted gears, specialized connectors, or advanced cooling systems that are essential for complex machines to work reliably, from medical devices and semiconductor manufacturing equipment to defense systems and automated industrial equipment. They focus on providing mission-critical components that are often custom-engineered and operate in demanding environments.
Very Brief History: Founded in 1930 as American Machine and Metals, AMETEK, Inc. evolved from a manufacturer of heavy machinery to a global leader in precision instruments and specialty materials. The company changed its name to AMETEK in the early 1960s to reflect this shift. Key milestones include entering the laboratory instruments business in 1965 and the water filtration equipment business in 1967. By 1983, AMETEK had grown to become a Fortune 500 company, largely driven by a strategy of strategic acquisitions and a focus on highly advanced products and materials.
"Street Stereotype": AMETEK is generally perceived by investors and analysts as a high-quality, well-managed industrial conglomerate known for its consistent organic growth, strong operational execution, and disciplined capital deployment, particularly through strategic acquisitions. It is often seen as a 'niche leader' providing mission-critical, highly engineered products with high switching costs in attractive end markets. Analysts typically hold a 'Buy' rating for the stock, reflecting confidence in its long-term growth prospects and financial performance.
Subsidiaries On Linked In*: RTDS Technologies — Mentioned in transcript
Zygo — Mentioned in transcript
Paragon Medical — Mentioned in transcript
Hughes-Treitler — Mentioned in transcript
Alphasense — Mentioned in transcript
Creaform — Mentioned in transcript and search results
Virtek — Mentioned in transcript
Abaco Systems — Mentioned in transcript
Rotron — Mentioned in transcript and search results
Solidstate Controls — Mentioned in search results
SEALTRON — Mentioned in search results
Hermetic Seal — Mentioned in search results
AMETEK Aegis — Mentioned in search results
Solartron Analytical — Mentioned in search results
Princeton Applied Research — Mentioned in search results
Fine Tubes — Mentioned in search results
Superior Tube — Mentioned in search results
Hamilton Precision Metals — Mentioned in search results
THERMOX — Mentioned in search results
Trace Analytical — Mentioned in search results
Chandler Engineering — Mentioned in search results
Customer Sectors & Example Clients: AMETEK serves a diverse range of customer sectors including process control, aerospace, power generation, general industrial applications, oil and gas, petrochemicals, pharmaceuticals, semiconductors, automation, food and beverage, laboratory settings, ultra-precision manufacturing, medical diagnostics (MedTech), and critical test and measurement tasks. Specific clients mentioned include a 'data center hyperscaler' for RTDS Technologies and customers utilizing 'leading semiconductor platforms' for Zygo. Based on their industry exposure, likely clients also include major aerospace and defense contractors (e.g., Boeing, Lockheed Martin), large pharmaceutical companies, leading semiconductor manufacturers (e.g., Intel, TSMC), medical device companies, and power utilities.
New Customers / Segments They'Re Targeting: AMETEK is actively targeting new customer sets and segments driven by powerful secular trends. This includes data center hyperscalers, who are utilizing RTDS Technologies for real-time digital simulation of power system infrastructure to derisk large-scale data center build-outs. They are also focused on the broader AI infrastructure build-out, with Zygo's precision metrology and optical solutions supporting advanced chip manufacturing. The company is seeing increased demand from defense modernization programs, including for UAVs, missile launchers, advanced computing, thermal management systems, and power systems. In MedTech, Paragon Medical is securing new design wins in orthopedics, drug delivery systems, and highly engineered medical components. Additionally, AMETEK's Power businesses are benefiting from the build-out of the power grid, providing critical fail-safes and ruggedized UPS systems for microgrids.
Sales Geographies And Expansion Plans: AMETEK currently sells its products globally, with strong performance across major regions. In Q2 2026, the U.S. saw low double-digit growth, driven by strength in Process and Aerospace & Defense businesses. Europe experienced mid-single-digit growth, primarily from its Power businesses. Asia achieved low double-digit growth, with strong performance in Automation and Process segments. The company maintains over 150 sites worldwide and has global shared service infrastructure in locations like India, Malaysia, Mexico, Serbia, and Poland. For expansion, AMETEK's top capital deployment priority is strategic acquisitions, with the acquisition of Indicor Instrumentation expected to close in the second half of 2026, further expanding its portfolio and global reach.
How Key Themes May Help/Hurt: The 'Data Centers '25: Energy Storage & Backup' theme is a significant tailwind for AMETEK. The 'insatiable and rapidly growing power demands of AI data centers and hyperscalers' directly drives demand for AMETEK's solutions. For example, RTDS Technologies provides real-time digital simulation for power system infrastructure, helping data center hyperscalers manage complex power profiles. Zygo's advanced metrology systems are crucial for manufacturing the advanced semiconductors that power AI, which is fundamental to data centers. Additionally, AMETEK's Power businesses contribute to the broader power grid build-out, offering ruggedized UPS systems for microgrids and natural gas turbine sensors, all vital for ensuring uninterrupted, high-quality power for data centers, especially given increasing grid instability. While the theme is largely beneficial, potential risks include general execution challenges in scaling manufacturing capacity and intensifying competition in certain areas, which could lead to pricing pressures.

3 Main Long-Term Bull Details

Alignment with Powerful Secular Growth Drivers: AMETEK's portfolio is strategically positioned to benefit from major long-term trends including the build-out of AI infrastructure, global defense modernization, energy security, innovation in MedTech, the commercial aerospace super cycle, and precision automation, providing broad-based and durable growth opportunities.
Mission-Critical Niche Solutions with High Barriers to Entry: The company provides highly differentiated, engineered, IP-driven products for mission-critical applications in regulatory-driven markets, leading to high switching costs and strong pricing power due to the high cost of failure for customers.
Proven AMETEK Growth Model: A disciplined approach integrating operational excellence, consistent new product development (evidenced by 25% new product vitality in Q2 2026), strategic acquisitions (such as the upcoming Indicor acquisition), and global market expansion drives sustained organic growth, core margin expansion, and robust cash flow generation.

3 Main Long-Term Bear Details

Acquisition Integration Risks: While acquisitions are a core growth strategy, the successful integration of acquired companies, such as the upcoming Indicor acquisition with its 10 business units, carries inherent execution risks related to realizing anticipated synergies, managing cultural differences, and maintaining operational performance.
Exposure to Cyclical Industrial Markets: Despite diversification, certain segments of AMETEK's business remain exposed to broader industrial cycles. A significant slowdown in global industrial capital expenditure or a broader economic downturn could impact demand for some of its products, potentially affecting revenue growth.
Intense Competition and Potential Commoditization: Although AMETEK focuses on niche and differentiated products, the broader electronic instruments and electromechanical devices markets are competitive. Over time, some product lines could face increased pricing pressures or commoditization from larger industrial players or new entrants, potentially eroding profit margins.

Competitors And Differentiation: AMETEK faces competition from a range of industrial technology companies including Roper Technologies, Teledyne Technologies, Keysight Technologies, Fortive, Danaher, Eaton, Honeywell, Parker Hannifin, and Generac. AMETEK differentiates itself by focusing on a 'highly differentiated, highly engineered IP-driven product portfolio' that provides 'mission-critical niche solutions'. Their products are often essential for customers' most difficult problems, operating in environments with 'high switching costs' and 'regulatory-driven markets' where the 'price of failure is high'. This positioning, combined with significant investment in R&D (25% new product vitality in Q2 2026) and a proven 'AMETEK growth model' emphasizing operational excellence and strategic acquisitions, allows them to maintain strong competitive advantages and pricing power.
Recent Performance & What The Market'S Focused On: AMETEK delivered an outstanding second quarter in 2026, with record sales of $2.04 billion, up 15% from the prior year, including 10% organic sales growth. Orders were exceptional, reaching a record $2.3 billion, up 28% overall and 25% organically, leading to a record backlog of $4.11 billion. Operating income was a record $544 million, an 18% increase, with excellent operating margins of 26.6% and core margins up 110 basis points. Diluted earnings per share were a record $2.09, up 17%, and the company generated strong free cash flow of $452 million, representing a 111% conversion rate. Reflecting these strong results and a positive outlook, AMETEK raised its full-year sales and earnings guidance. The market is currently focused on the sustainability of this strong order growth, particularly from the multi-year infrastructure build-out driven by AI, power grid modernization, and defense spending. Investors are also closely watching the successful integration of the Indicor acquisition and its anticipated contribution to future growth and profitability.

Revenue Segments And Estimated Mix: Electronic Instruments Group (EIG) — Mix: ~64.7%; Source: Q2 2026 transcript; Trend: Sales up 14% YoY, organic sales up 7%
Electromechanical Group (EMG) — Mix: ~35.3%; Source: Q2 2026 transcript; Trend: Sales up 17% YoY, organic sales up 15%
Product Brands: RTDS Technologies
Zygo
Paragon Medical
Hughes-Treitler
Alphasense
Creaform
Virtek
Abaco
Rotron
PDT
Solidstate Controls
SEALTRON
Hermetic Seal
AMETEK SCP
AMETEK Aegis
Solartron Analytical
Princeton Applied Research
Signal Recovery
Fine Tubes
Superior Tube
AMETEK Coining
Hamilton Precision Metals
AMETEK SMP Eighty Four
AMETEK SMP Wallingford
THERMOX
Trace Analytical
Western Research
Chandler Engineering

Bull / Bear Details

AMETEK's investment thesis remains bullish as of 2026-08-31, driven by its diversified portfolio strategically aligned with powerful secular growth themes inclu

Thesis

AMETEK's investment thesis remains bullish as of 2026-08-31, driven by its diversified portfolio strategically aligned with powerful secular growth themes including AI infrastructure, defense modernization, power grid build-out, and MedTech. Exceptional operational execution, evidenced by record organic growth, robust margin expansion, and strong cash flow, coupled with a disciplined acquisition strategy like Indicor, positions the company for sustained superior shareholder value.

Bull case

AMETEK is experiencing exceptional organic growth and record orders, leading to a $4.11 billion backlog, with 80% expected to ship within 12 months. This is fueled by a multi-year infrastructure build-out across critical secular drivers such as AI infrastructure (semiconductor metrology, data center power), defense modernization, commercial aerospace, and power grid expansion, ensuring durable demand for its mission-critical products.
The company demonstrates outstanding operational execution, delivering robust core margin expansion (up 110 bps in Q2 2026) and strong free cash flow generation (up 37% to $452 million, 111% conversion). AMETEK's highly differentiated, IP-driven product portfolio in niche markets allows for effective pricing power, consistently offsetting inflation and tariffs, contributing to sustained profitability and financial strength.
AMETEK maintains a disciplined and robust acquisition strategy, with the $5 billion Indicor Instrumentation acquisition expected to close in H2 2026, projected to yield 10-12% cost synergies. Coupled with internal investments in new product vitality (25% in Q2 2026) and AI deployment for efficiency and product enhancement, this strategy continuously expands its market reach and technological leadership.

Bear case

Significant execution risks persist in integrating large acquisitions like Indicor, managing cultural differences, and realizing the projected 10-12% cost synergies. Delays or challenges in the integration process could lead to operational disruptions, higher-than-anticipated costs, and a failure to achieve the expected financial benefits, potentially impacting profitability and shareholder value.
Despite current broad-based strength, AMETEK remains susceptible to potential cyclical slowdowns or shifts in specific industrial end markets or geopolitical tensions. A deceleration in global capital expenditure, particularly in areas like semiconductor manufacturing or general industrial automation, could temper future demand for its products and impact organic growth rates, challenging its positive outlook.
The intensifying competitive landscape across AMETEK's niche markets, including potential new entrants or aggressive pricing strategies from existing competitors, could lead to long-term pricing pressures and margin erosion. While AMETEK currently benefits from high switching costs and regulatory-driven markets, sustained competitive intensity could eventually challenge its ability to maintain premium pricing and market share.

Bull / Bear Case

Bear Case: Despite strong recent results, AMETEK faces significant execution risks associated with the large $5 billion Indicor Instrumentation acquisition. Challenges in integrating 10 business units, managing cultural differences, and realizing the projected 10-12% cost synergies could lead to operational disruptions, higher costs, and a failure to achieve expected financial benefits. While diversified, AMETEK remains susceptible to potential cyclical slowdowns or shifts in specific industrial end markets, such as semiconductor manufacturing or general industrial automation, which could temper future organic growth rates. The intensifying competitive landscape across its niche markets, including potential new entrants or aggressive pricing strategies, could lead to long-term pricing pressures and margin erosion, challenging AMETEK's ability to maintain premium pricing and market share.
Bull Case: AMETEK's investment thesis is strongly supported by its exceptional Q2 2026 performance, featuring double-digit organic sales growth (10%), record orders (up 28% organically), and a robust $4.11 billion backlog, with 80% expected to ship within 12 months. The company is strategically aligned with powerful secular growth drivers, including AI infrastructure, defense modernization, the commercial aerospace super cycle, power grid build-out, and MedTech innovation, ensuring durable demand for its mission-critical products. Operational excellence is evident in strong core margin expansion (up 110 bps) and outstanding free cash flow generation (up 37%, 111% conversion). Furthermore, AMETEK's disciplined acquisition strategy, highlighted by the pending $5 billion Indicor Instrumentation acquisition with projected 10-12% cost synergies, and continuous investment in new product development (25% vitality) and AI deployment, positions it for sustained long-term growth and shareholder value creation.
More Compelling & Why: Bear. Despite strong Q2 results and raised guidance, the stock's -6.02% underperformance relative to SPY post-earnings suggests the market is factoring in risks. Given a likely premium P/E ratio, the significant execution risks associated with the large Indicor acquisition and potential for growth deceleration make the bear case more compelling. My view would flip if AMETEK demonstrates sustained successful integration of Indicor, consistently exceeds organic growth guidance, and provides clear evidence of synergy realization, thereby justifying a premium valuation.

Key Factors5 rows

Key Factor	Why It Matters	What To Watch	What It Signals	Where/How To Track	Free Alt Data	Paid Alt Data
Sustained mid-to-high single-digit organic sales growth in segments aligned with AI infrastructure, power grid build-out, defense modernization, commercial aerospace, and MedTech.	These secular growth drivers represent 'about half' of AMETEK's business and are key to its multi-year infrastructure build-out thesis, indicating long-term demand.	Organic sales growth rates for EIG (Process/Semiconductor, Power, Aerospace) and EMG (MedTech, Automation, Aerospace & Defense) in Q3 2026 and Q4 2026. Specific mentions of new orders or project wins related to data center hyperscalers (RTDS), AI infrastructure (Zygo), and MedTech (Paragon).	Bullish if organic sales growth in these combined segments remains robust (e.g., > 7-10% collectively) and new project wins continue. Bearish if growth in these key areas decelerates below overall company average or if project activity slows.	Company earnings calls and press releases for Q3 2026 (expected November 2026) and Q4 2026 (expected February 2027).	Google Trends: 'AI infrastructure investment', 'data center power solutions', 'defense modernization spending', 'MedTech innovation'. Industry association reports (e.g., Semiconductor Industry Association, Aerospace Industries Association).	IDC/Gartner: Data center CapEx forecasts, semiconductor equipment spending. BloombergNEF: Power grid investment trends.
Sustained organic orders growth and maintenance of a strong backlog, particularly the conversion rate of backlog to sales.	Record orders and backlog provide strong visibility into future revenue, indicating robust demand across AMETEK's attractive end markets and the durability of its growth drivers.	Organic orders growth percentage in Q3 2026 and Q4 2026. Total backlog level at the end of Q3 2026 and Q4 2026. Book-to-bill ratio.	Bullish if organic orders growth remains strong (e.g., above 20% like Q1/Q2) and backlog remains above $4 billion with a book-to-bill > 1.0. Bearish if organic orders growth decelerates significantly (e.g., below 10%) or backlog declines.	Company earnings calls and press releases for Q3 2026 (expected November 2026) and Q4 2026 (expected February 2027).	Industry reports on capital expenditure trends in semiconductor, aerospace, and power infrastructure.	Bloomberg Terminal: AME order book analysis, industry-specific CapEx forecasts.
Successful closure of the $5 billion Indicor Instrumentation acquisition.	This significant acquisition is a key capital deployment priority, expected to add high-quality businesses and deliver 10-12% cost synergies, materially impacting AMETEK's future growth and profitability.	Official announcement of the acquisition closing. Confirmation of the $5 billion deployment. Updates on integration progress and synergy realization.	Bullish if the acquisition closes as expected in H2 2026 and initial integration updates confirm synergy targets (10-12% cost synergy). Bearish if delayed or cancelled, or if synergy expectations are significantly reduced.	Company press releases, SEC filings (8-K), subsequent earnings calls (Q3 2026 and Q4 2026).	Industry news outlets covering M&A in the industrial instruments sector.	S&P Capital IQ: M&A transaction database for similar deals.
Achievement of strong free cash flow to net income conversion, maintaining the 2026 guidance of 110-115%.	High cash conversion demonstrates efficient working capital management and strong operational performance, providing capital for strategic acquisitions and shareholder returns.	Free cash flow to net income conversion ratio in Q3 2026 and Q4 2026. Any revisions to the full-year 2026 guidance range of 110-115%.	Bullish if conversion remains within or above the 110-115% guidance. Bearish if conversion falls significantly below the guidance range, indicating potential working capital issues or lower operational efficiency.	Company earnings calls and press releases for Q3 2026 (expected November 2026) and Q4 2026 (expected February 2027).	N/A	Refinitiv Eikon: AME cash flow statement analysis, peer group cash conversion comparisons.
Continued expansion of core operating margins, driven by productivity gains and pricing power.	Core margin expansion reflects AMETEK's operational efficiency, ability to offset inflation, and the value of its differentiated product portfolio, directly impacting profitability.	Core operating margin percentage for EIG and EMG in Q3 2026 and Q4 2026. Updates on enterprise-wide productivity target achievement (currently $160 million for 2026).	Bullish if core operating margins continue to expand (e.g., > 50 basis points YoY) and productivity targets are met or exceeded. Bearish if core margins contract or productivity initiatives falter.	Company earnings calls and press releases for Q3 2026 (expected November 2026) and Q4 2026 (expected February 2027).	Producer Price Index (PPI) for industrial machinery and electronic components (Bureau of Labor Statistics).	FactSet: AME margin analysis, industry cost structure benchmarks.

Key Reported Metrics, Reratings Triggers & Results3 rows

EPS growth is a key bottom-line profitability metric, reflecting the company's ability to translate strong sales and operational efficiency into shareholder val

Upcoming print · 2026-10-29

Key reported metrics
Metric	Last period	Why it matters
Diluted Earnings Per Share Growth	17%	EPS growth is a key bottom-line profitability metric, reflecting the company's ability to translate strong sales and operational efficiency into shareholder value. It indicates effective cost management, pricing power, and overall financial performance.
Organic Orders Growth	25%	As a leading indicator, strong organic orders growth signals robust future revenue and backlog conversion. It demonstrates continued demand for AMETEK's mission-critical products and validates its strategic positioning in high-growth secular markets, providing visibility into future performance.
Organic Sales Growth	10%	This metric directly reflects AMETEK's underlying business health and demand across its diversified end markets. Sustained organic growth validates the company's strategic alignment with powerful secular drivers like AI infrastructure, MedTech, and Aerospace & Defense.

Key Questions

Will AMETEK successfully close the Indicor Instrumentation acquisition in Q3 2026 and provide initial indications of achieving its projected 10-12% cost synergi

Will AMETEK successfully close the Indicor Instrumentation acquisition in Q3 2026 and provide initial indications of achieving its projected 10-12% cost synergies?

Question 2: Can AMETEK maintain strong organic sales growth in Q3 2026, effectively converting its record $4.11 billion backlog, particularly given the projected deceleration in organic revenue growth?
Question 3: Will AMETEK sustain its core operating margin expansion in Q3 2026, driven by continued productivity gains and pricing power, especially as the Indicor integration commences?

Earnings Transcript SummaryTable

2026-08-04 · 2026Q2 Earnings Call

3 Things Management Is Most Focused On	Call Takeaway & Tone	Prior Quarter'S Y/Y Growth By Segment	3 Things Analysts Most Pressed On (And Mgmt Responses)	Revenue Segments
3 Things Management Is Most Focused On1. Strategic Acquisitions and Capital Deployment: Management is actively pursuing strategic acquisitions, with the Indicor Instrumentation acquisition expected to close in the second half of the year, and maintains a robust pipeline of opportunities. 2. Investing in Businesses for Long-Term Sustainable Growth: The company is committed to internal investments, evidenced by a strong new product vitality of 25% in the quarter, and highlighted innovations like Hughes-Treitler's MicroFoil and Alphasense's A2GLF oxygen sensor. 3. Capitalizing on Broadening Secular Growth Drivers: Management emphasizes AMETEK's strategic alignment with powerful secular trends, including AI infrastructure, power grid build-out, defense modernization, commercial aerospace, MedTech, and precision automation, which are driving multi-year infrastructure investment.	Call Takeaway & ToneThe overall takeaway of the call was highly positive and confident. AMETEK delivered an outstanding second quarter, exceeding expectations with record double-digit organic sales growth, exceptional orders growth, strong core margin expansion, and robust cash flow. Management expressed strong confidence in the company's strategic positioning within attractive secular growth markets such as AI infrastructure, power grid modernization, and Aerospace & Defense, which are driving a multi-year infrastructure build-out. The tone was consistently upbeat, with management frequently using terms like 'fantastic results,' 'exceptional,' 'outstanding,' and 'record' to describe performance and outlook. The Indicor acquisition is progressing well, and the company's disciplined growth model is expected to continue delivering superior shareholder value.	Prior Quarter'S Y/Y Growth By SegmentIn Q1 2026, overall sales were up 11% (organic sales up 5%). EIG sales were up 11%. EMG sales were up 13%. Aerospace & Defense experienced high single-digit growth.	3 Things Analysts Most Pressed On (And Mgmt Responses)1. End Market and Regional Data Points / Broadening Growth: Analysts inquired about the breadth of growth beyond data centers. Management responded by confirming strong, broad-based growth across all major regions (U.S. and Asia strongest, Europe mid-single digits) and diversified end markets, including AI infrastructure, power grid build-out, and Aerospace & Defense, indicating a multi-year infrastructure build-out. 2. Backlog Duration and AI/Data Center Business Contribution / Pricing Power: Analysts asked about the backlog's duration and the portion of business tied to data center/AI, and if this informed pricing ability. Management stated the backlog was $4.11 billion with 80% expected to ship within 12 months, and a positive book-to-bill of 1.12. They estimated about half of the business is tied to the combined 'bucket' of AI/data center, military modernization, commercial aerospace, and power infrastructure, and confirmed that AMETEK's differentiated, IP-driven products allow for pricing power to offset inflation. 3. Sustainability of Order Growth and Q3 Organic Revenue Deceleration: Analysts questioned the sustainability of strong order growth and the rationale behind the projected deceleration in Q3 organic revenue. Management affirmed continued strong orders, with June being a record month and July also performing very well, attributing durability to mission-critical products and multi-year infrastructure investments. They noted that the Q3 guidance includes a degree of 'AMETEK prudence or conservatism.'	Revenue SegmentsOverall sales were up 15% (organic sales up 10%). Electronic Instruments Group (EIG) sales were up 14% (organic sales up 7%). Electromechanical Group (EMG) sales were up 17% (organic sales up 15%). Process businesses sales were up high teens (organic high single-digit). Aerospace & Defense organic sales growth was mid-teens. Power businesses organic sales growth was mid-single-digits. Automation & Engineered Solutions organic growth was mid-teens.

Transcript TidbitsTable

2026-08-04

About Expanding Eligible Market	About Competition	About The Broader Industry	Where Things Are Headed	Updates On Theme	Broader Themes Emerging	Bullish-Leaning Quotes (Short)
About Expanding Eligible MarketAMETEK is strategically expanding its eligible market by aligning its portfolio with powerful secular growth drivers, including AI infrastructure, defense modernization, energy security, MedTech innovation, commercial aerospace, and precision automation. The company's RTDS Technologies business secured a key order from a data center hyperscaler for power system infrastructure simulation, and its Zygo business supports accelerated investment in AI infrastructure with precision metrology and optical solutions for advanced chips. Paragon Medical is experiencing exceptional growth driven by new design wins in orthopedics, drug delivery systems, and highly engineered medical components. Additionally, Hughes-Treitler introduced MicroFoil, a new lightweight heat exchanger technology for aerospace, defense, and industrial cooling applications, and Alphasense launched the world's first galvanic lead-free oxygen sensor for environmental, health, and safety applications. Geographically, the U.S. and Asia showed the strongest growth, with Process and Aerospace & Defense performing well in the U.S., and Automation and Process strong in Asia. Power businesses are benefiting from the broader build-out of the power grid.	About CompetitionAMETEK emphasizes its position as a "niche leader" providing "mission-critical products" that solve difficult customer problems, operating in environments with "high switching costs and regulatory-driven markets" where "the price of failure is high." These factors enable the company to offset inflation and tariffs with pricing power. The acquisition of Indicor Instrumentation is expected to add "high-quality businesses with leading market positions in attractive niche markets, very differentiated technologies, strong IP positions, deep domain expertise," and a "higher profitable recurring revenue stream of 50% of revenue." The FARO acquisition, combined with Creaform, establishes a "leadership position" in 3D metrology, complementing existing capabilities.	About The Broader IndustryThe broader industry is characterized by a "broadening infrastructure investment environment" and a "changing macroeconomic environment." Key drivers include the "sizable demand for advanced semiconductors" fueled by AI, increasing focus on "defense modernization and energy security" due to geopolitical uncertainties and volatile energy prices, and "innovation-led momentum in MedTech." The commercial aerospace sector is experiencing a "super cycle" with an "almost decade-long backlog," while "precision automation" demand is improving. The company believes it is in the "beginning stages of a multiyear infrastructure build-out" driven by these factors.	Where Things Are HeadedAMETEK raised its full-year 2026 sales and earnings guidance, now expecting overall sales to be up approximately 10% with organic sales up mid- to high single digits, and diluted EPS in the range of $8.20 to $8.30. For Q3 2026, sales are anticipated to be up high single digits with adjusted EPS of $2.08 to $2.10. The company maintains a robust acquisition pipeline and expects the Indicor acquisition to close in the second half of the year, anticipating 10% to 12% cost synergies. The backlog of $4.11 billion, with 80% expected to ship within 12 months, provides strong visibility into 2027. Internally, AMETEK increased its enterprise-wide productivity target to $160 million for the year and is actively deploying AI to improve efficiency, accelerate growth across all functions, and enhance product development, aiming to shorten design cycles significantly. The FARO business is also expected to show "substantial margin upside over the next 6 to 12 months."	Updates On ThemeEnergy	Broader Themes EmergingA "multiyear infrastructure build-out" is emerging as a significant overarching theme, driven by the convergence of AI infrastructure needs, power grid modernization, defense modernization, and the commercial aerospace super cycle.	Bullish-Leaning Quotes (Short)"AMETEK delivered fantastic results in the second quarter with double-digit organic sales growth, excellent orders growth, strong core margin expansion, outstanding cash flow generation and record earnings ahead of our expectations." "Orders were again exceptional in the quarter with continued broad-based growth across all AMETEK divisions." "We also raised our full year sales and earnings guidance to reflect our outstanding first half results and our positive outlook for the balance of the year." "I believe we're in the beginning stages of a multiyear infrastructure build-out, and we're incredibly well positioned." "June was the strongest month for orders in the quarter in all time. So we had a record for the month of June. And we just finished July, and the orders were very good. So it's continuing."

NotesTable

Date	Comment	Comment Type	Comment Sentiment	Link	Price Reaction
2026-08-04	AMETEK's Q2 2026 earnings call was highly positive, reporting record double-digit organic sales growth, exceptional orders, and raised full-year guidance. Management expressed strong confidence in secular growth drivers like AI infrastructure and defense. The stock's 3.12% return (T+2) significantly outperformed SPY's 1.44%, indicating the market perceived the results and outlook very favorably, aligning with the company's bullish messaging.	Earnings Transcript	Neutral		+3.12% (vs SPY: +1.68%)